Pyrimidine-sulfamides and their use as endothelian receptor...

Details Pyrimidine-sulfamides and their use as endothelian receptor... Pyrimidine-sulfamides and their use as endothelian receptor...

2003-11-10

2008-11-18

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S296000, C544S319000

Reexamination Certificate

active

07452896

ABSTRACT:
The invention relates to novel sulfamic acid amides of General Formula (I) and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as endothelin receptor antagonists.

REFERENCES:
patent: 4233294 (1980-11-01), Maurer et al.
patent: 0 658 548 (1997-11-01), None
patent: 0 633 259 (1999-01-01), None
patent: 0 526 708 (2000-10-01), None
patent: 0 882 719 (2001-05-01), None
patent: 0 743 307 (2001-09-01), None
patent: 0 959 072 (2002-09-01), None
patent: 1549494 (1968-12-01), None
patent: WO-96/19459 (1996-06-01), None
patent: WO-02/053557 (2002-07-01), None
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1010, 1996.
Rubanyi et al., Endothelins: Molecular Biology, Biochemistry, Pharmacology, Physiology, and Pathophysiology, Pharmacological Reviews, vol. 46, No. 3, pp. 325-415, 1994.
Volker Breu, et al.; “In vitro characterization of RO 46-2005, a novel synthetic non-peptide endothelin antagonist of ETAand ETBreceptors”; FEBS 13244; vol. 334(2); Nov. 1993; pp. 210-214; On CD under filename Breu—20050526160232.pdf.
D. J. Brown, et al.; “Pyrimidine Reactions VI.* The Amination of Chloropyrimidines with n-Alkylamines”; Aust. J. Chem; 1964; 17, pp. 794-802; On CD as filename Brown—20050526162958.pdf.
Elliott Cohen, et al.; “Sulfamoyl Chloride, Sulfamides and Sulfimide”; J. Am. Chem. Soc.; 1962; vol. 84; pp. 1994-2002. On CD as filename Cohen—20050526162403.pdf.
Donald G. Crosby, et al.; “n-Butyl 5-Chloro-2-pyrimidoxyacetate-A Plant Growth Regulator Analog”; J. Org. Chem.; 1960; vol. 25; pp. 1916-1919. On CD as filename Crosby—20050526162918.pdf.
Georges Dewynter, et al.; “Synthese de ‘sulfahydantoines’ chirales. Aspects stereochimiques et protection regiospecifique.”; Tetrahedron; 1993; vol. 49(1); pp. 65-76; On CD as filename Dewynter—20050526163615.pdf.
Roger P. Dickinson, et al.; “Thromboxane Modulating Agents. 3. 1H-Imidazol-1-yulalkyl- and 3-Pyridinylalkyl-Substituted 3-[2-[Arylsulfonyl)amino]ethyl]benzenepropanoic Acid Derivatives as Dual Thromboxane Synthase Inhibitor/Thromboxane Receptor Antagonists”; J. Med. Chem.; 1997; vol. 40; p. 3442. On CD as filename Dickinson—20050526162822.pdf.
Wolfgang, Gohring, et al.; “Development of a Process to Prepare 2-Cyanopyrimidine on Commercial Scale”; Chimia; 1996; vol. 50; pp. 538-543; On CD as filename Goehring—20050526160404.pdf.
Roderich Graf; “Umsetzungen mit N-Carbonyl-sulfamidsaure-chlorid1,2), I Uber das Sulfamidsaurechlorid”; 1959; vol. 92; p. 509; On CD as filename Graf—20050526162550.pdf.
Stig Andre Jacobsen, et al.; “Phenylation of pyrimidinones using diphenyliodonium salts”; J. Chem. Soc. Perkin Trans 1; 1999; pp. 3265-3268; On CD as filename Jacobsen—20050526163157.pdf.
Marc Julia, et al.; “Sur quelques hydroxy et methoxy-3 phenoxy-ethylamines chlorees analogues des tryptamines hallucinogenes”; Chim. Ther. 1965; vol. 4; pp. 334-343; On CD as filename Julia—20050526162250.pdf.
J. A. Kloek, et al.; “An Improved Synthesis of Sulfamoyl Chlorides”; J. Org. Chem; 1976; vol. 41; p. 4028; On CD as filename Kloek—20050526162645.pdf.
Yusuhisa Kohara, et al.; “Synthesis and Angiotensin II Receptor Antagonistic Activities of Benzimidazole Derivatives Bearing Acidic Heterocycles as Novel Tetrazole Bioisosteres”; J. Med. Chem; 1996; vol. 39; pp. 5228-5235; On CD as filename Kohara—20050526162200.pdf.
Henry C. Koppel, et al.; “Pyrimidines. X. (Antibiotics. II) Synthesis of Bacimethrin, 2-Methoxy Analog of Thiamine and Related Alkoxypyrimidines”; J. Org. Chem; 1962; vol. 27; pp. 3614-3617; On CD as filename Koppel—20050526163054.pdf.
C. Maggiali, et al.; “Effetti Anti H1-Istaminici E Antimuscarinici Di Composti 2-E 4-[Benzil-(2-Dimetilaminoetil)Amino]Pirimidinici”; Farmaco, Ed. Sci.; 1988; vol. 43; pp. 277-292; On CD as filename Maggiali—20050526163243.pdf.
Jerry March; Advanced Organic Chemistry, 4thEdition; 1994; p. 499; On CD as filename March—20050526162122.pdf.
Marvin A. McMillen, et al.; “Endothelins: Polyfunctional Cytokines”; J. Am. Coll. Surg.; 1995; vol. 180; p. 621: On CD as filename McMillen—20050525104659.pdf.
E. D. Morgan; “Synthesis of p-Alkylphenylacetic Acids”; Tetrahedron; 1967; vol. 23; p. 1735; On CD as filename Morgan—20050526163434.pdf.
Werner Neidhart, et al.; “Discovery of RO 48-5695: A Potent Mixed Endothelin Receptor Antagonist Optimized From Bosentan”; Bioorg. Med. Chem. Lett.; 1997; vol. 7; pp. 2223-2228; On CD as filename Neidhart 2—20050526161918.pdf.
Werner Neidhart, et al.; “The Discovery of Nonpeptide Endothelin Receptor Angagonists. Progression towards Bosentan”; Chimia; vol. 50; pp. 519-524; On CD as filename Neidhart—20050526160756.pdf.
Richard A. Nugent, et al.; “Pyrimidine Thioethers: A Novel Class of HIV-1 Reverse Transcriptase Inhibitors with Activity Against BHAP-Resistant HIV”; J. Med. Chem.; 1998; vol. 41; pp. 3793-3803; On CD as filename Nugent—20050526162015.pdf.
Yoshihiro Ogawa, et al.; “Molecular Cloning of a Non-Isopeptide-Selective Human Endothelin Receptor”; BBRC; 1991; vol. 178; pp. 248-255; On CD as filename Ogawa—20050525110759.pdf.
Eliot H. Ohlstein, et al.; “Endothelin-1 Modulates Vascular Smooth Muscle Structure and Vasomotion: Implications in Cardiovascular Pathology”; Drug. Dev. Res.; 1993; vol. 29; pp. 108-128; On CD as filename Ohlstein—20050525110638.pdf.
Richard E. Olson, et al.; “Orally Active Isoxazoline Glycoprotein IIb/IIIa Antagonists with Extended Duration of Action”; J. Med. Chem.; 1999; pp. 1178-1192; On CD as filename Oslon—20050526162724.pdf.
G. M. Rubanyi, et al.; “Endothelins: Molecular Biology, Biochemistry, Pharmacology, Physiology, and Pathophysiology”; Pharmacol. Rev.; 1994; vol. 46(3); p. 328; On CD as filename Rubanyi—20050525105453.pdf.
Takeshi Sakurai, et al.; “Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor”; Nature; 1990; vol. 348; p. 732; On CD as filename Sakurai—20050525110520.pdf.
Michael J. Sumner, et al.; “Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction” Brit. J. Pharmacol.; 1992; vol. 107; p. 858; On CD as filename Sumner—20050526160142.pdf.
Matthew J. Tozer, et al.; “4-Chlorobenzyl Sulfonamide and Sulfamide Derivatives of Histamine Homologues: The Design of Potent Histamine H, Receptor Antagonists”; Bioorg. Med. Chem. Lett.; 1999; vol. 9; p. 3103; On CD as filename Tozer—20050526163521.pdf.
von Gunther Weiss, et al; “Herstellung und Reaktionen von N-Monoalkyl-amidosulfonylchloriden”; Leibigs Ann. Chem.; 1969; vol. 729; p. 40; On CD as filename Weiss—20050526162455.pdf.
Masashi Yanagisawa, et al.; “A novel potent vasoconstrictor peptide produced by vascular endothelial cells”; Nature; 1988; vol. 332; p. 411; On CD as filename Yanagisawa—20050525110419.pdf.
H. Arai, et al.; Nature; 1990; vol. 348; p. 730; Will be forwarded at a later date.
The International Search Report issued for the Parent PCT Application.

Affiliated with

Also associated with

Rating

Pyrimidine-sulfamides and their use as endothelian receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine-sulfamides and their use as endothelian receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine-sulfamides and their use as endothelian receptor... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4031598